Mast cell-derived TNF contributes to airway hyperreactivity, inflammation, and TH2 cytokine production in an asthma model in mice

Journal of Allergy and Clinical Immunology

Volumn 120, Issue 1, 2007, Pages 48-55

  Nakae, Susumu ^a   Ho, Lien H ^a   Yu, Mang ^a   Monteforte, Rossella ^a   Iikura, Motoyasu ^a   Suto, Hajime ^a,b   Galli, Stephen J ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JUNTENDO UNIVERSITY   (Japan)

Author keywords

Airway hyperreactivity; asthma; cytokines; mast cells; TNF

Indexed keywords

EOSINOPHIL PEROXIDASE; MYELOPEROXIDASE; OVALBUMIN; TUMOR NECROSIS FACTOR;

ALLERGIC ASTHMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRONCHUS HYPERREACTIVITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; INFLAMMATION; MAST CELL; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SENSITIZATION; TH2 CELL;

ANIMALS; ASTHMA; BRONCHIAL HYPERREACTIVITY; CYTOKINES; DISEASE MODELS, ANIMAL; EOSINOPHIL PEROXIDASE; LUNG; MAST CELLS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OVALBUMIN; PEROXIDASE; PNEUMONIA; TH2 CELLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34250829615     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2007.02.046     Document Type: Article

References (56)

1. Wills-Karp M. Immunologic basis of antigen-induced airway hyperresponsiveness. Annu Rev Immunol 17 (1999) 255-281
2. Cohn L., Elias J.A., and Chupp G.L. Asthma: mechanisms of disease persistence and progression. Annu Rev Immunol 22 (2004) 789-815
3. Fort M.M., Cheung J., Yen D., Li J., Zurawski S.M., Lo S., et al. IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. Immunity 15 (2001) 985-995
4. Metcalfe D.D., Baram D., and Mekori Y.A. Mast cells. Physiol Rev 77 (1997) 1033-1079
5. Turner H., and Kinet J.P. Signalling through the high-affinity IgE receptor FcεRI. Nature 402 (1999) B24-B30
6. Rivera J. Molecular adapters in FcεRI signaling and the allergic response. Curr Opin Immunol 14 (2002) 688-693
7. Kawakami T., and Galli S.J. Regulation of mast-cell and basophil function and survival by IgE. Nat Rev Immunol 2 (2002) 773-786
8. Galli S.J., Kalesnikoff J., Grimbaldeston M.A., Piliponsky A.M., Williams C.M., and Tsai M. Mast cells as "tunable" effector and immunoregulatory cells: recent advances. Annu Rev Immunol 23 (2005) 749-786
9. Marshall J.S. Mast-cell responses to pathogens. Nat Rev Immunol 4 (2004) 787-799
10. Galli S.J., Nakae S., and Tsai M. Mast cells in the development of adaptive immune responses. Nat Immunol 6 (2005) 135-142
11. Williams C.M.M., and Galli S.J. The diverse potential effector and immunoregulatory roles of mast cells in allergic disease. J Allergy Clin Immunol 105 (2000) 847-859
12. Marone G., Triggiani M., Genovese A., and Paulis A.D. Role of human mast cells and basophils in bronchial asthma. Adv Immunol 88 (2005) 97-160
13. Bradding P., Walls A.F., and Holgate S.T. The role of the mast cell in the pathophysiology of asthma. J Allergy Clin Immunol 117 (2006) 1277-1284
14. Kips J.C., Anderson G.P., Fredberg J.J., Herz U., Inman M.D., Jordana M., et al. Murine models of asthma. Eur Respir J 22 (2003) 374-382
15. Boyce J.A., and Austen K.F. No audible wheezing: nuggets and conundrums from mouse asthma models. J Exp Med 201 (2005) 1869-1873
16. Lloyd C.M., Gonzalo J.A., Coyle A.J., and Gutierrez-Ramos J.C. Mouse models of allergic airway disease. Adv Immunol 77 (2001) 263-295
17. Brewer J.M., Conacher M., Hunter C.A., Mohrs M., Brombacher F., and Alexander J. Aluminium hydroxide adjuvant initiates strong antigen-specific Th2 responses in the absence of IL-4- or IL-13-mediated signaling. J Immunol 163 (1999) 6448-6454
18. Korsgren M., Erjefalt J.S., Korsgren O., Sundler F., and Persson C.G. Allergic eosinophil-rich inflammation develops in lungs and airways of B cell-deficient mice. J Exp Med 185 (1997) 885-892
19. Mayr S.I., Zuberi R.I., Zhang M., de Sousa-Hitzler J., Ngo K., Kuwabara Y., et al. IgE-dependent mast cell activation potentiates airway responses in murine asthma models. J Immunol 169 (2002) 2061-2068
20. Brusselle G.G., Kips J.C., Tavernier J.H., van der Heyden J.G., Cuvelier C.A., Pauwels R.A., et al. Attenuation of allergic airway inflammation in IL-4 deficient mice. Clin Exp Allergy 24 (1994) 73-80
21. Takeda K., Hamelmann E., Joetham A., Shultz L.D., Larsen G.L., Irvin C.G., et al. Development of eosinophilic airway inflammation and airway hyperresponsiveness in mast cell-deficient mice. J Exp Med 186 (1997) 449-454
22. Williams C.M., and Galli S.J. Mast cells can amplify airway reactivity and features of chronic inflammation in an asthma model in mice. J Exp Med 192 (2000) 455-462
23. Hamelmann E., Vella A.T., Oshiba A., Kappler J.W., Marrack P., and Gelfand E.W. Allergic airway sensitization induces T cell activation but not airway hyperresponsiveness in B cell-deficient mice. Proc Natl Acad Sci U S A 94 (1997) 1350-1355
24. Nakae S., Komiyama Y., Yokoyama H., Nambu A., Umeda M., Iwase M., et al. IL-1 is required for allergen-specific Th2 cell activation and the development of airway hypersensitivity response. Int Immunol 15 (2003) 483-490
25. Schmitz N., Kurrer M., and Kopf M. The IL-1 receptor 1 is critical for Th2 cell type airway immune responses in a mild but not in a more severe asthma model. Eur J Immunol 33 (2003) 991-1000
26. Rudmann D.G., Moore M.W., Tepper J.S., Aldrich M.C., Pfeiffer J.W., Hogenesch H., et al. Modulation of allergic inflammation in mice deficient in TNF receptors. Am J Physiol Lung Cell Mol Physiol 279 (2000) L1047-L1057
27. Broide D.H., Stachnick G., Castaneda D., Nayar J., and Sriramarao P. Inhibition of eosinophilic inflammation in allergen-challenged TNF receptor p55/p75-and TNF receptor p55-deficient mice. Am J Respir Cell Mol Biol 24 (2001) 304-311
28. Kanehiro A., Lahn M., Makela M.J., Dakhama A., Fujita M., Joetham A., et al. Tumor necrosis factor-α negatively regulates airway hyperresponsiveness through γδ T cells. Am J Respir Crit Care Med 164 (2001) 2229-2238
29. Nakae S., Lunderius C., Ho L.H., Schafer B., Tsai M., and Galli S.J. TNF can contribute to multiple features of ovalbumin-induced allergic inflammation of the airways in mice. J Allergy Clin Immunol 119 (2007) 680-686
30. Duttlinger R., Manova K., Chu T.Y., Gyssler C., Zelenetz A.D., Bachvarova R.F., et al. W-sash affects positive and negative elements controlling c-kit expression: ectopic c-kit expression at sites of kit-ligand expression affects melanogenesis. Development 118 (1993) 705-717
31. Korner H., Cook M., Riminton D.S., Lemckert F.A., Hoek R.M., Ledermann B., et al. Distinct roles for lymphotoxin-α and tumor necrosis factor in organogenesis and spatial organization of lymphoid tissue. Eur J Immunol 27 (1997) 2600-2609
32. Barnden M.J., Allison J., Heath W.R., and Carbone F.R. Defective TCR expression in transgenic mice constructed using cDNA-based α- and β-chain genes under the control of heterologous regulatory elements. Immunol Cell Biol 76 (1998) 34-40
33. Young J.D., Liu C.C., Butler G., Cohn Z.A., and Galli S.J. Identification, purification, and characterization of a mast cell-associated cytolytic factor related to tumor necrosis factor. Proc Natl Acad Sci U S A 84 (1987) 9175-9179
34. Gordon J.R., and Galli S.J. Mast cells as a source of both preformed and immunologically inducible TNF-α/cachectin. Nature 346 (1990) 274-276
35. Gordon J.R., and Galli S.J. Release of both preformed and newly synthesized tumor necrosis factor α (TNF-α)/cachectin by mouse mast cells stimulated via the FcεRI. A mechanism for the sustained action of mast cell-derived TNF-α during IgE-dependent biological responses. J Exp Med 174 (1991) 103-107
36. Suto H., Nakae S., Kakurai M., Sedgwick J.D., Tsai M., and Galli S.J. Mast cell-associated TNF promotes dendritic cell migration. J Immunol 176 (2006) 4102-4112
37. Hu Z.Q., Kobayashi K., Zenda N., and Shimamura T. Tumor necrosis factor-α- and interleukin-6-triggered mast cell development from mouse spleen cells. Blood 89 (1997) 526-533
38. Wright H.V., Bailey D., Kashyap M., Kepley C.L., Drutskaya M.S., Nedospasov S.A., et al. IL-3-mediated TNF production is necessary for mast cell development. J Immunol 176 (2006) 2114-2121
39. W-sh/W-sh mice as a model for investigating mast cell biology in vivo. Am J Pathol 167 (2005) 835-848
40. Varga S.M., Beckman N.A., Chu M., and Braciale T.J. Sensitive detection and quantitation of mouse eosinophils in tissues using an enzymatic eosinophil peroxidase assay: its use to rapidly measure pulmonary eosinophilia during experimental respiratory syncytial virus infection of mice. J Immunol Methods 262 (2002) 111-120
41. Laan M., Cui Z.H., Hoshino H., Lotvall J., Sjostrand M., Gruenert D.C., et al. Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. J Immunol 162 (1999) 2347-2352
42. Dinarello C.A. Proinflammatory cytokines. Chest 118 (2000) 503-508
43. Stassen M., Arnold M., Hultner L., Muller C., Neudorfl C., Reineke T., et al. Murine bone marrow-derived mast cells as potent producers of IL-9: costimulatory function of IL-10 and kit ligand in the presence of IL-1. J Immunol 164 (2000) 5549-5555
44. Hultner L., Kolsch S., Stassen M., Kaspers U., Kremer J.P., Mailhammer R., et al. In activated mast cells, IL-1 up-regulates the production of several Th2-related cytokines including IL-9. J Immunol 164 (2000) 5556-5563
45. Stassen M., Muller C., Arnold M., Hultner L., Klein-Hessling S., Neudorfl C., et al. IL-9 and IL-13 production by activated mast cells is strongly enhanced in the presence of lipopolysaccharide: NF-kappa B is decisively involved in the expression of IL-9. J Immunol 166 (2001) 4391-4398
46. Nakae S., Suto H., Kakurai M., Sedgwick J.D., Tsai M., and Galli S.J. Mast cells enhance T cell activation: importance of mast cell-derived TNF. Proc Natl Acad Sci U S A 102 (2005) 6467-6472
47. Nakae S., Suto H., Iikura M., Kakurai M., Sedgwick J.D., Tsai M., et al. Mast cells enhance T cell activation: importance of mast cell costimulatory molecules and secreted TNF. J Immunol 176 (2006) 2238-2248
48. Moffatt J.D. What targets have knockouts revealed in asthma?. Pharmacol Ther 107 (2005) 343-357
49. Bradding P., Roberts J.A., Britten K.M., Montefort S., Djukanovic R., Mueller R., et al. Interleukin-4, -5, and -6 and tumor necrosis factor-α in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. Am J Respir Cell Mol Biol 10 (1994) 471-480
50. Wershil B.K., Wang Z.S., Gordon J.R., and Galli S.J. Recruitment of neutrophils during IgE-dependent cutaneous late phase reactions in the mouse is mast cell-dependent: partial inhibition of the reaction with antiserum against tumor necrosis factor-α. J Clin Invest 87 (1991) 446-453
51. Thomas P.S., Yates D.H., and Barnes P.J. Tumor necrosis factor-α increases airway responsiveness and sputum neutrophilia in normal human subjects. Am J Respir Crit Care Med 152 (1995) 76-80
52. Halasz A., Cserhati E., Magyar R., Kovacs M., and Cseh K. Role of TNF-α and its 55 and 75 kDa receptors in bronchial hyperreactivity. Respir Med 96 (2002) 262-267
53. Babu K.S., Davies D.E., and Holgate S.T. Role of tumor necrosis factor α in asthma. Immunol Allergy Clin North Am 24 (2004) 583-597
54. Howarth P.H., Babu K.S., Arshad H.S., Lau L., Buckley M., McConnell W., et al. Tumour necrosis factor (TNFα) as a novel therapeutic target in symptomatic corticosteroid dependent asthma. Thorax 60 (2005) 1012-1018
55. Berry M.A., Hargadon B., Shelley M., Parker D., Shaw D.E., Green R.H., et al. Evidence of a role of tumor necrosis factor α in refractory asthma. N Engl J Med 354 (2006) 697-708
56. Erzurum S.C. Inhibition of tumor necrosis factor α for refractory asthma. N Engl J Med 354 (2006) 754-758